The MGuard coronary stent: safety, efficacy, and clinical utility

Vasc Health Risk Manag. 2015 Sep 18:11:533-9. doi: 10.2147/VHRM.S68007. eCollection 2015.

Abstract

Atheromatous and thrombotic embolization during percutaneous coronary revascularization is a feared complication that may cause impaired myocardial reperfusion even with a patent epicardial vessel. The MGuard stent is a cobalt chromium bare metal stent with a porous net attached to its outer surface that has been designed to prevent thrombus fragmentation and distal embolization during stent implantation. This review summarizes the available evidence supporting the use of the MGuard stent in different scenarios such as lesions with high thrombus burden, saphenous vein graft interventions, coronary perforations, or carotid lesions.

Keywords: Coronary artery disease; complication; coronary stent; myocardial infarction; no-reflow phenomenon; thrombus.

Publication types

  • Review

MeSH terms

  • Animals
  • Chromium Alloys
  • Coronary Angiography
  • Coronary Artery Disease / complications
  • Coronary Artery Disease / diagnosis
  • Coronary Artery Disease / therapy*
  • Coronary Thrombosis / complications
  • Coronary Thrombosis / diagnosis
  • Coronary Thrombosis / therapy*
  • Embolic Protection Devices*
  • Embolism / diagnosis
  • Embolism / etiology
  • Embolism / prevention & control*
  • Humans
  • Myocardial Infarction / complications
  • Myocardial Infarction / diagnosis
  • Myocardial Infarction / therapy*
  • Percutaneous Coronary Intervention / adverse effects
  • Percutaneous Coronary Intervention / instrumentation*
  • Prosthesis Design
  • Risk Factors
  • Stents*
  • Surface Properties
  • Treatment Outcome

Substances

  • Chromium Alloys